Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
BactProNET: a structural-mechanistic platform for interpreting target-mediated antimicrobial resistance
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 20 May 2026

BactProNET: a structural-mechanistic platform for interpreting target-mediated antimicrobial resistance

  • Ke Wang1 na1,
  • Yiru Liu1 na1,
  • Xue Wang1,
  • Haitao Zhou1,
  • Longfei Chen2 &
  • …
  • Jingyun Xu2 

Scientific Reports (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Computational biology and bioinformatics
  • Drug discovery
  • Microbiology

Abstract

Antibiotics are the frontline therapy for bacterial infections, yet their efficacy is critically threatened by antimicrobial resistance (AMR), a crisis largely driven by mutations in protein targets. While this mechanism is prevalent, data on its structural impact remains highly dispersed, and existing resources such as CARD, ResFinder, MEGARes, and NDARO prioritize gene identification over mechanistic insight. To address this gap, we developed BactProNET, a bioinformatics platform focused specifically on target-mediated resistance caused by amino acid substitutions in antibiotic target proteins. It provides structural and evolutionary analysis distinct from broader AMR databases. Its core innovation is a multi-level data integration that establishes a wild-type reference system and enables comparative analysis with mutant proteins to facilitate mechanistic inference. The platform integrates curated resistance mutations with AlphaFold2-predicted three-dimensional (3D) structures, both wild-type and mutant molecular docking models defining an “optimal binding” baseline and its potential disruption by resistance mutations, and integrated phylogenetic and sequence alignment views. BactProNET currently houses data on 44 bacterial species, 107 protein targets, 196 mutation sites (representing 243 unique amino acid substitutions), 323 antibiotics, and 640 wild-type plus 1,697 mutant docking models. The platform is accessible via an interface with embedded basic local alignment search tool (BLAST) and multiple sequence alignment (MSA) tools. As a one-stop platform for target-mediated resistance, it facilitates the interpretation of AMR’s molecular mechanisms and provides a data-driven foundation for the rational design of next-generation antimicrobial drugs.

Similar content being viewed by others

Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning

Article 10 January 2022

A generative artificial intelligence approach for the discovery of antimicrobial peptides against multidrug-resistant bacteria

Article Open access 03 October 2025

Plasmid-mediated phenotypic noise leads to transient antibiotic resistance in bacteria

Article Open access 23 March 2024

Acknowledgements

The authors would like to thank the NHC Key Laboratory of Parasite and Vector Biology (National Institute of Parasitic Diseases, Chinese Center for Diseases Control and Prevention) (Grant No. NHCKFKT2025-2) and the Key Project in National Science Research in Higher Education Institutions of Anhui Province (Grant No. 2022AH051236) for financial support. We also thank all colleagues and collaborators who contributed to this study.

Funding

This project was supported by NHC Key Laboratory of Parasite and Vector Biology (National Institute of Parasitic Diseases, Chinese Center for Diseases Control and Prevention) (NHCKFKT2025-2) and Key Project in National Science Research in Higher Education Institutions of Anhui Province (2022AH051236).

Author information

Author notes
  1. These authors contributed equally: Ke Wang and Yiru Liu.

Authors and Affiliations

  1. School of Clinical Medicine, Wannan Medical University, Wuhu, 241002, China

    Ke Wang, Yiru Liu, Xue Wang & Haitao Zhou

  2. School of Basic Medical Sciences, Wannan Medical University, Wuhu, 241002, China

    Longfei Chen & Jingyun Xu

Authors
  1. Ke Wang
    View author publications

    Search author on:PubMed Google Scholar

  2. Yiru Liu
    View author publications

    Search author on:PubMed Google Scholar

  3. Xue Wang
    View author publications

    Search author on:PubMed Google Scholar

  4. Haitao Zhou
    View author publications

    Search author on:PubMed Google Scholar

  5. Longfei Chen
    View author publications

    Search author on:PubMed Google Scholar

  6. Jingyun Xu
    View author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Longfei Chen or Jingyun Xu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (download PDF )

Supplementary Material 2 (download XLSX )

Supplementary Material 3 (download XLSX )

Supplementary Material 4 (download XLSX )

Supplementary Material 5 (download XLSX )

Supplementary Material 6 (download XLSX )

Supplementary Material 7 (download XLSX )

Supplementary Material 8 (download XLSX )

Supplementary Material 9 (download XLSX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, K., Liu, Y., Wang, X. et al. BactProNET: a structural-mechanistic platform for interpreting target-mediated antimicrobial resistance. Sci Rep (2026). https://doi.org/10.1038/s41598-026-53667-1

Download citation

  • Received: 06 February 2026

  • Accepted: 13 May 2026

  • Published: 20 May 2026

  • DOI: https://doi.org/10.1038/s41598-026-53667-1

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • BactProNET
  • Antibiotic resistance
  • Database
  • Target protein
  • Target-mediated resistance
  • Amino acid mutation
  • Molecular docking
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research